NIT
INSY

NumerixS Investment Technologies’s Insys Therapeutics, Inc. INSY Stock Holding History

NumerixS Investment Technologies’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,900
Closed -$193K – 1394
2016
Q2 		$193K Sell
14,900
-21,250
-59% -$310K 0.03% 719
2016
Q1 		$578K Buy
36,150
+5,855
+19% +$111K 0.07% 414
2015
Q4 		$867K Buy
30,295
+17,583
+138% +$487K 0.11% 257
2015
Q3 		$362K Buy
12,712
+3,212
+34% +$118K 0.04% 477
2015
Q2 		$341K Buy
+9,500
New +$296K 0.05% 470

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

NumerixS Investment Technologies's INSY Position: Q3 2016 in Review

NumerixS Investment Technologies sold out of Insys Therapeutics, Inc. (INSY) in Q3 2016, closing a stake of 14,900 shares — an estimated $193K sold.

NumerixS Investment Technologies first reported a position in INSY in Q2 2015 and held it in 5 quarters. The position peaked at $867K in Q4 2015. 138 funds tracked by Wall St. Rank hold INSY as of Q3 2016.

  • NumerixS Investment Technologies reported no remaining Insys Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • NumerixS Investment Technologies sold 14,900 Insys Therapeutics, Inc. shares in Q3 2016, an estimated $193K.
  • NumerixS Investment Technologies first reported a position in Insys Therapeutics, Inc. in Q2 2015 and held it in 5 quarters.
  • NumerixS Investment Technologies's Insys Therapeutics, Inc. position peaked at $867K in Q4 2015.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2016.

Based on NumerixS Investment Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.